M. Viot
About
In The Last Decade
M. Viot
19 papers receiving 445 citations
Peers
Comparison fields: 5 of 74
- Oncology 204
- Pulmonary and Respiratory Medicine 188
- Otorhinolaryngology 116
- Radiology, Nuclear Medicine and Imaging 94
- Clinical Biochemistry 75
Countries citing papers authored by M. Viot
This map shows the geographic impact of M. Viot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Viot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Viot more than expected).
Fields of papers citing papers by M. Viot
This network shows the impact of papers produced by M. Viot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Viot. The network helps show where M. Viot may publish in the future.
Co-authorship network of co-authors of M. Viot
This figure shows the co-authorship network connecting the top 25 collaborators of M. Viot. A scholar is included among the top collaborators of M. Viot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Viot. M. Viot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | Ceftriaxone monotherapy for the treatment of febrile neutropenia in patients with solid tumors: a prospective study of 100 episodes. | 2 |
| 3 | Standards, Options et Recommandations (SOR) pour la surveillance et la prévention des infections nosocomiales en cancérologie | 5 |
| 4 | Standards, Options and Recommendations (SOR)for the surveillance and the prevention of cross infections in oncology | 1 |
| 5 | 10 | |
| 6 | 17 | |
| 7 | 34 | |
| 8 | [Standards, Options and Recommendations (SOR) for the surveillance and the prevention of cross infections in oncology. Fédération Nationale des Centres de Lutte Contre le Cancer]. | 6 |
| 9 | 192 | |
| 10 | 5 | |
| 11 | [Standards, Options, and Recommendations for the management of brief neutropenias. Fedération Nationale des Centres de Lutte Contre le Cancer]. | 3 |
| 12 | 58 | |
| 13 | 15 | |
| 14 | Early adhesion of bacteremic strains of Staphylococcus epidermidis to polystyrene: influence of hydrophobicity, slime production, plasma, albumin, fibrinogen, and fibronectin. | 30 |
| 15 | 39 | |
| 16 | [Secretion by Candida albicans of substances stimulating the proliferation of a cell line of malpighian epithelioma of the mouth]. | 2 |
| 17 | Value of urinary hydroxyproline and bone isoenzyme of alkaline phosphatase in the early detection and follow-up of bone metastasis in breast cancer patients. | 12 |
| 18 | 3 | |
| 19 | 24 | |
| 20 | The value of serum alkaline phosphatase alpha 1 isoenzyme in the diagnosis of liver metastases. Preliminary results. | 12 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.